Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Change in International mRCC Database Consortium (IMDC) prognostic category and implications for efficacy of second-line targeted therapy. Davis, I. D., Xie, W., Pezaro, C., Donskov, F., Wells, C., Agarwal, N., Srinivas, S., Yuasa, T., Beuselinck, B., Wood, L., Ernst, D., Kanesvaran, R., Knox, J. J., Pantuck, A. J., Saleem, S., Alva, A., Rini, B. I., Lee, J., Choueiri, T. K., Heng, D. AMER SOC CLINICAL ONCOLOGY. 2016
View details for DOI 10.1200/jco.2016.34.2_suppl.534
View details for Web of Science ID 000378109100527